NOCIL Shuts Trading Window March 31 Ahead of FY26 Results Release

CHEMICALS
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
NOCIL Shuts Trading Window March 31 Ahead of FY26 Results Release
Overview

NOCIL Limited is closing its trading window for designated employees and connected individuals, effective March 31, 2026. The window will reopen 48 hours after the company announces its audited financial results for the fiscal year ending March 31, 2026, following SEBI (Prohibition of Insider Trading) Regulations.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

NOCIL Limited is closing its trading window for designated employees and connected individuals, effective March 31, 2026. This restriction means company insiders cannot trade shares until 48 hours after the announcement of the audited financial results for the fiscal year ending March 31, 2026, adhering to SEBI regulations.

Trading Window Details

The closure begins at the start of business on Tuesday, March 31, 2026. It will remain in effect until 48 hours after the Board of Directors approves and declares the audited financial results for both the quarter and the full fiscal year ended March 31, 2026.

Importance of the Closure

This measure is a standard corporate compliance practice aimed at preventing potential insider trading. By limiting trading by individuals with access to non-public, price-sensitive information, NOCIL ensures market fairness and transparency. The company's adherence to this practice aligns with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and its own code of conduct, reinforcing strong corporate governance.

Company Background

Established in 1961 and headquartered in Mumbai, NOCIL Limited is India's largest manufacturer and supplier of rubber chemicals. The company serves the tire and other rubber processing industries both domestically and internationally with products including PILFLEX, PILNOX, PILCURE, and PILGARD. NOCIL operates manufacturing facilities in Navi Mumbai and Dahej. The company has a history of updating its Code of Conduct to meet evolving SEBI regulations, with recent amendments made around February 2026 to align with new insider trading rules.

Impact on Trading

During this period, designated employees and individuals connected with NOCIL are prohibited from trading the company's shares. Consequently, external investors must wait for the official announcement of the audited financial results and the subsequent 48-hour waiting period before any trading activity by insiders can resume.

Regulatory Context

No specific risks were outlined in the company's filing regarding this trading window closure; it is described as a routine regulatory procedure.

Industry Peers

NOCIL's competitors in the chemical sector include Oriental Carbon & Chemical Limited (OCCL), which supplies Insoluble Sulphur and Sulphuric Acid to the tyre industry. Other companies in the broader specialty chemicals market, such as Camlin Fine Sciences Ltd. and Yasho Industries Ltd., are also notable players. While OCCL competes for tyre industry material supply, its primary products differ, focusing on items like insoluble sulphur.

Looking Ahead

NOCIL will inform the stock exchanges separately about the date for the Board meeting where the Audited Financial Results will be considered. Investors should watch for the official announcement of these results for the quarter and full financial year ended March 31, 2026, as they will offer key performance indicators for the company.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.